Antidepressants, withdrawal, and addiction; where are we now?
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Controversy continues with regard to antidepressants and withdrawal. Recent debates have focused on the prevalence and length of withdrawal, and some continue to state that withdrawal from these compounds constitutes ‘addiction’. In this editorial we examine the evidence underlying these recent debates. We acknowledge gaps in knowledge, and make suggestions for how the field can progress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“evidence indicates that this is likely to be less common for short term users,11 and more common for long-term users.5,12,13”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“A large number of patients will be partial responders to antidepressants, with just over one-third achieving full remission with their first prescribed antidepressant (Rush et al., 2006).”
A Meta-Analysis of Response Rates in Web- or Internet-Based Surveys
Cook, C., Heath, F., & Thompson, R. L. (2000) · Educational and Psychological Measurement · doi:10.1177/00131640021970934 · Cited by 2,396 · cited 1×
“Though undoubtedly rich in qualitative data, these convenience sample surveys are not generally accepted as quantitative analyses with clear criteria set by journals for inclusion of quantitative data (Bethlehem, 2010; Cook et al., 2000).”
Addiction Is a Brain Disease, and It Matters
Leshner, A. I. (1997) · Science · doi:10.1126/science.278.5335.45 · Cited by 1,615
Bethlehem, J. (2010) · International Statistical Review · doi:10.1111/j.1751-5823.2010.00112.x · Cited by 1,315 · cited 1×
“Though undoubtedly rich in qualitative data, these convenience sample surveys are not generally accepted as quantitative analyses with clear criteria set by journals for inclusion of quantitative data (Bethlehem, 2010; Cook et al., 2000).”
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574 · cited 2×
“…randomised controlled trials (RCTs), which included randomised double-blind studies with drug interruption using unstructured and, subsequently, standardised assessment measures such as the Discontinuation-Emergent Signs and Symptoms (DESS) checklist (Oehrberg et al., 1995; Rosenbaum et al., 1998).”
Davies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387 · cited 2×
“A recent review, published in Addictive Behaviours, commissioned by the United Kingdom All Party Parliamentary Group for Prescribed Drug Dependence, has suggested that symptoms of antidepressant withdrawal are similar to those seen with drugs of dependence; that the prevalence is significantly higher than originally p…”
Wiles, N., Thomas, L., Abel, A., Ridgway, N., Turner, N., Campbell, J., Garland, A., Hollinghurst, S., Jerrom, B., Kessler, D., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61552-9 · Cited by 340 · cited 1×
“However, these trials are not necessarily representative of antidepressant use in clinical practice (Wiles et al., 2013).”
Le Noury, J., Nardo, J. M., Healy, D., Jureidini, J., Raven, M., Tufanaru, C., & Abi-Jaoude, E. (2015) · BMJ · doi:10.1136/bmj.h4320 · Cited by 329 · cited 1×
“However, the story of paroxetine has been marred with controversy; it has been the focus of negative documentaries, and trial data have needed to be reanalysed because of the potential downplaying of adverse events (Le Noury et al., 2015).”
Paroxetine in the Treatment of Panic Disorder a Randomised, Double-Blind, Placebo-Controlled Study
Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K., & Manniche, P. M. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.167.3.374 · Cited by 261 · cited 4×
“Participants in the paroxetine arm underwent abrupt cessation from daily doses of 20–60 mg after 12 weeks treatment for panic disorder (Oehrberg et al., 1995), 20 mg after 12 weeks for generalised anxiety disorder (Baldwin et al., 2006) and 20 mg after 24 weeks for social anxiety disorder (Lader et…”
Influential
Research works printed but not linked: 1
- Weller IVD Ashby D Brook R Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitors Medicines and Healthcare Products Regulatory Agency London 2005
Cited by
Mental health misinformation on social media: Review and future directions
Starvaggi, I., Dierckman, C., & Lorenzo-Luaces, L. (2024) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2023.101738 · Cited by 88
Guy, A., Brown, M., Lewis, S., & Horowitz, M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320967183 · Cited by 77
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
Horowitz, M. A., Framer, A., Hengartner, M. P., Sørensen, A., & Taylor, D. (2023) · CNS Drugs · doi:10.1007/s40263-022-00960-y · Cited by 76
“toms were reported by patients rather than using objective withdrawal questionnaires [4, 14].”
BackgroundMethodInfluential(2022) · doi:10.1192/bja.2021.62 · Cited by 73
Framer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73
Metadata
- Authors
- Jauhar, S., Hayes, J., Goodwin, G. M., Baldwin, D. S., Cowen, P. J., & Nutt, D. J.
- Affiliations
- King's College London (GB)
- University College London (GB)
- University of Oxford (GB)
- University of Southampton (GB)
- Imperial College London (GB)
- Corresponding author
- Jauhar, Sameer
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2019-05-21
- Volume
- 33
- Issue
- 6
- Pages
- 655-659
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- PMC
- PMC7613097
- OpenAlex
- W2939418131
- Cited by
- 31
- References
- 33
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 4 · 2022: 7 · 2021: 2 · 2020: 2 · 2019: 3
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- royal college of physicians of edinburgh (JMAS Sim Fellowship)
- national institute for health research
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- antidepressants, antidepressant discontinuation
- MeSH terms
- Antidepressive Agents, Humans, Substance Withdrawal Syndrome, Behavior, Addictive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressants, withdrawal, and addiction; where are we now? https://app.cochat.ai/papers/10.1177/0269881119845799
- The paper
- Jauhar, S., Hayes, J., Goodwin, G. M., Baldwin, D. S., Cowen, P. J., & Nutt, D. J. (2019). Antidepressants, withdrawal, and addiction; where are we now? Journal of Psychopharmacology. https://doi.org/10.1177/0269881119845799
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.